Pharmicell Co., Ltd. (KRX:005690)
12,480
-200 (-1.58%)
At close: Jul 25, 2025, 3:30 PM KST
Pharmicell Market Cap
Pharmicell has a market cap or net worth of 748.85 billion as of July 25, 2025. Its market cap has increased by 122.86% in one year.
Market Cap
748.85B
Enterprise Value
n/a
Revenue
23.94B
Ranking
n/a
PE Ratio
n/a
Stock Price
12,480.00
Market Cap Chart
Since August 29, 1995, Pharmicell's market cap has increased from 40.96B to 748.85B, an increase of 1,728.25%. That is a compound annual growth rate of 10.20%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 25, 2025 | 748.85B | 50.72% |
Dec 30, 2024 | 496.83B | 36.41% |
Dec 28, 2023 | 364.22B | -46.28% |
Dec 29, 2022 | 678.05B | -13.33% |
Dec 30, 2021 | 782.30B | -24.57% |
Dec 30, 2020 | 1,037.07B | 103.77% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 75.87T |
Celltrion | 39.24T |
ALTEOGEN | 24.69T |
Yuhan | 9,152.41B |
SK Biopharmaceuticals | 8,034.94B |
Peptron | 6,663.04B |
HLB Co., Ltd. | 6,558.63B |
PharmaResearch | 5,797.42B |